[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:enteropathy-associated-t-cell-lymphoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":63,"states":64},"Enteropathy-Associated T-Cell Lymphoma",8,6,[8,16,23,30,37,43,49,56],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT03719105","Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia\u002FLymphoma",[12],"Early Phase 1","RECRUITING","2026-08-26T02:17:44.240289Z","2026-05-05T02:43:28.474501Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT05996185","Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma",[20],"Phase 2","2026-08-26T02:16:52.995882Z","2026-05-05T02:43:28.341848Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":28,"content_modified":29},"NCT07055477","A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)",[27],"Phase 1","2026-08-26T02:18:46.137046Z","2026-05-05T02:43:27.673466Z",{"nct_id":31,"title":32,"phases":33,"status":13,"updated_at":35,"content_modified":36},"NCT05475925","A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas",[34],"Phase 1\u002FPhase 2","2026-08-26T02:15:28.524219Z","2026-05-05T02:43:27.068416Z",{"nct_id":38,"title":39,"phases":40,"status":13,"updated_at":41,"content_modified":42},"NCT05010005","A Study of Ruxolitinib and Duvelisib in People With Lymphoma",[27],"2026-08-26T02:16:01.079019Z","2026-05-05T02:43:26.685721Z",{"nct_id":44,"title":45,"phases":46,"status":13,"updated_at":47,"content_modified":48},"NCT05978141","A Registry for People With T-cell Lymphoma",[],"2026-08-26T02:16:20.336282Z","2026-05-13T02:55:06.403613Z",{"nct_id":50,"title":51,"phases":52,"status":53,"updated_at":54,"content_modified":55},"NCT07691450","Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma",[27],"NOT_YET_RECRUITING","2026-08-26T02:16:42.787115Z","2026-07-19T19:36:05.157190Z",{"nct_id":57,"title":58,"phases":59,"status":60,"updated_at":61,"content_modified":62},"NCT03690011","Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells",[27],"ACTIVE_NOT_RECRUITING","2026-08-03T03:05:09.265674Z","2026-05-05T02:43:27.128098Z",[],[65,69,73,77,80,83,86],{"state":66,"count":67,"slug":68},"New York",5,"new-york",{"state":70,"count":71,"slug":72},"California",4,"california",{"state":74,"count":75,"slug":76},"Connecticut",3,"connecticut",{"state":78,"count":75,"slug":79},"Florida","florida",{"state":81,"count":75,"slug":82},"Massachusetts","massachusetts",{"state":84,"count":75,"slug":85},"Ohio","ohio",{"state":87,"count":75,"slug":88},"Texas","texas"]